Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Indivior Pharmaceuticals Inc (INDV)

Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
S&P 500, MidCap 400, and SmallCap 600 Welcome New Members as Indexes Rebalance for 2026

The S&P 500’s latest rebalance reveals how the index quietly upgrades itself by promoting winners like Carvana and CRH and removing underperformers through a process that more closely resembles disciplined...

APP : 389.35 (-15.69%)
ENPH : 52.65 (+41.23%)
PRIM : 147.10 (-5.12%)
HL : 22.83 (-2.60%)
SOLS : 65.51 (-1.13%)
MKTX : 161.55 (+0.79%)
CHAR : 10.53 (-0.14%)
CWST : 104.25 (+1.04%)
UA : 6.54 (+6.69%)
BWA : 50.49 (+3.95%)
PRGO : 14.75 (+4.31%)
IRDM : 19.55 (-0.36%)
Why This Top 100 Stock to Buy Is Getting Cheaper Even as It Soars Higher

Virginia-based Indivior, a developer of opioid addiction treatments, continues to hold down a place in Barchart’s Top 100 Stocks to Buy. Up 192% in 2025, its P/E is declining despite the stock’s gains...

INDV : 34.52 (-2.62%)
Indivior Announces Inclusion in the S&P SmallCap 600® Index

RICHMOND, Va. , Dec. 22, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) (" Indivior PLC " or the " Company ") today announced that it will be added to the S&P SmallCap 600 ® index,...

INDV : 34.52 (-2.62%)
New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations

RICHMOND, Va. , Dec. 17, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) today announced results from a randomized, double-blind clinical trial published in  JAMA Network Open.  The...

INDV : 34.52 (-2.62%)
CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

NEW YORK , Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open...

PRIM : 147.10 (-5.12%)
HL : 22.83 (-2.60%)
SOLS : 65.51 (-1.13%)
CWST : 104.25 (+1.04%)
UA : 6.54 (+6.69%)
BWA : 50.49 (+3.95%)
PRGO : 14.75 (+4.31%)
IRDM : 19.55 (-0.36%)
MHK : 130.24 (+4.40%)
CEVA : 20.86 (+0.77%)
INDV : 34.52 (-2.62%)
DY : 361.89 (-7.61%)
Indivior Concludes Legacy U.S. Department of Justice Matter

RICHMOND, Va. , Nov. 20, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) today announced the Company has concluded the legacy U.S. Department of Justice (DOJ) matter by paying in full the outstanding...

INDV : 34.52 (-2.62%)
Indivior to Participate in the Piper Sandler 37th Annual Healthcare Conference

RICHMOND, Va. , Nov. 19, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the Piper Sandler 37 th Annual Healthcare Conference:

INDV : 34.52 (-2.62%)
Indivior Presents New Real-World Evidence at AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine

RICHMOND, Va. , Nov. 3, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) presented three new scientific posters at the Academy of Managed Care Pharmacy (AMCP) Nexus 2025 conference last week,...

INDV : 34.52 (-2.62%)
Indivior Reports Third Quarter 2025 Financial Results and Raises Full-Year 2025 Financial Guidance

RICHMOND, Va. , Oct. 30, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) today reported its financial results for the third quarter ended September 30, 2025, and provided a business update.

INDV : 34.52 (-2.62%)
Indivior to Participate in the Stifel 2025 Healthcare Conference

RICHMOND, Va. , Oct. 28, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the Stifel 2025 Healthcare Conference:

INDV : 34.52 (-2.62%)

Barchart Exclusives

As AMD Stock Breaks Below Key Support on Earnings Selloff, Should You Buy the Dip?
AMD stock is tanking as the management’s Q1 guidance fails to impress shareholders. But Northland Capital analysts recommend buying AMD shares on the post-earnings pullback. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar